Dr. Nazli A. Janjua, MD

Dr. Janjua practices at Asia Pacific Comprehensive Stroke Network in Pomona, California.

Dr. Janjua's NPI, 1790719292, was assigned on July 10, 2006. Dr. Janjua graduated from Sind Medical College in 1997. Dr. Janjua's New York license number on file is 224509.

Dr. Janjua's primary practice is Asia Pacific Comprehensive Stroke Network, at 2895 N Towne Ave, Pomona, CA 91767 in Los Angeles County. The practice phone is (909) 962-8441.

Dr. Janjua's primary practice is Asia Pacific Comprehensive Stroke Network in Pomona, California. Dr. Janjua is also affiliated with Pomona Valley Hospital Medical Center. Dmand AI also links Dr. Janjua to 2 more hospitals and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Janjua practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Janjua's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Janjua is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Janjua's licenses on file in 5 states: New York, California, New Jersey, Hawaii and Illinois.

Dmand AI lists cerebrovascular disease among the conditions Dr. Janjua treats.

CMS data shows 98 Medicare services from Dr. Janjua across 5 procedure codes in 2024, for 71 Medicare patients. Medicare paid $13,142 for them.

CMS counts 71 Medicare patients who saw Dr. Janjua in 2024. The largest group is 65 to 74, with 32 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Janjua's median patient age at 65, with 59% women.

In 2024, Dr. Janjua wrote 115 Medicare Part D claims for 28 patients. 83% of them were for generic drugs. CMS names the drug for 65 of them, across 4 drugs with 11 or more claims each, at $6,774 in total drug cost. In 2023, CMS named 118 claims across 6 drugs.

Dr. Janjua accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 34 papers to Dr. Janjua, published from 2011 to 2025. 2023 was the busiest year, with 6. The most frequent topics are Endovascular Procedures, Stroke and Ischemic Stroke. Dr. Janjua has published most often in J Vasc Interv Neurol. Dr. Janjua's most frequent co-authors are Ameer Elsayed Hassan, DO, Johanna Therese Fifi, MD and Waldo R. Guerrero, MD.

CMS Open Payments shows 196 general payments to Dr. Janjua from 24 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 55% of the total. Penumbra, Inc. paid the most, $8,398.

Dr. Janjua graduated from Sind Medical College in 1997.

Dr. Janjua is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and LA Care. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.